jili x super ace

jili x super ace By MARC LEVY HARRISBURG, Pa. (AP) — Democratic Sen. Bob Casey of Pennsylvania conceded his reelection bid to Republican David McCormick on Thursday, as a statewide recount showed no signs of closing the gap and his campaign suffered repeated blows in court in its effort to get potentially favorable ballots counted. Casey’s concession comes more than two weeks after Election Day, as a grindingly slow ballot-counting process became a spectacle of hours-long election board meetings, social media outrage, lawsuits and accusations that some county officials were openly flouting the law. Republicans had been claiming that Democrats were trying to steal McCormick’s seat by counting “illegal votes.” Casey’s campaign had accused of Republicans of trying to block enough votes to prevent him from pulling ahead and winning. In a statement, Casey said he had just called McCormick to congratulate him. “As the first count of ballots is completed, Pennsylvanians can move forward with the knowledge that their voices were heard, whether their vote was the first to be counted or the last,” Casey said. The Associated Press called the race for McCormick on Nov. 7, concluding that not enough ballots remained to be counted in areas Casey was winning for him to take the lead. As of Thursday, McCormick led by about 16,000 votes out of almost 7 million ballots counted. That was well within the 0.5% margin threshold to trigger an automatic statewide recount under Pennsylvania law. But no election official expected a recount to change more than a couple hundred votes or so, and Pennsylvania’s highest court dealt him a blow when it refused entreaties to allow counties to count mail-in ballots that lacked a correct handwritten date on the return envelope. Republicans will have a 53-47 majority next year in the U.S. Senate. Follow Marc Levy at twitter.com/timelywriterWild first season in expanded Big 12 comes down to final weekend

Judge grants request from prosecutors to dismiss election interference case against President-elect Donald Trump

Datamine Laboratory Sector Overview

NoneMoECC, Umm Salal SC roll out initiative to foster environmental sustainability

BREAKING: ‘He is quitting’ - Swans bombshell as John Longmire to step down after 14 years

Liverpool leads as the class of the Champions League this season, dumping title holder Real Madrid into an almost unbelievable 24th place in the 36-team standings. No one felt the embarrassment of Madrid’s 2-0 loss at Anfield more than Kylian Mbappé, the superstar added in the offseason by the storied club that also was European champion against Liverpool in the finals of 2022 and 2018. Mbappé had a penalty saved in the second half and was earlier dumped on his behind by Conor Bradley’s perfect tackle in an instant viral moment. Monaco missed a chance to go second in the table, giving up a lead playing with 10 men from the 58th minute in a 3-2 loss at home to Benfica. Swiss forward Zeki Amdouni scored the winning goal in the 88th. Borussia Dortmund, the beaten finalist against Madrid in May, is up to fourth place after beating Dinamo Zagreb 3-0. Champions League standout Jamie Gittens now has four goals in five games, curling a rising shot in the 41st to open the scoring. The best comeback was at PSV Eindhoven, where the home team trailed Shakhtar Donetsk by two goals in the 87th minute before a 3-2 win was sealed by United States forward Ricardo Pepi’s goal deep in stoppage time. US defender Cameron Carter-Vickers scored an embarrassing own goal for Celtic — playing a no-look pass far beyond goalkeeper Kasper Schmeichel — in a 1-1 draw with Club Brugge. Liverpool’s stand-in right back Bradley was a standout Wednesday, playing a key pass that set up Alexis Mac Allister to score the opening goal in the 52nd. After Mbappé’s penalty was pushed away by goalkeeper Caoimhín Kelleher in the 61st, Liverpool star Mo Salah missed with his spot-kick in the 70th, before substitute Cody Gakpo sealed the win with a header in the 77th. Madrid now has lost three of five games after defeats at Lille and at home to AC Milan. The record 15-time European champion has another tough trip next, at fifth-place Atalanta on Dec. 10. Congo teammates Ngal’Ayel Mukau and Silas impressed in wins for Lille and Red Star Belgrade. Mukau scored twice in 12th-place Lille’s 2-1 win at Bologna and Silas leveled for Red Star in a 5-1 rout of Stuttgart, though he barely celebrated his goal. Silas is on loan with the Serbian champion from Stuttgart. Aston Villa drew 0-0 with Juventus. AP soccer: https://apnews.com/hub/soccerBrazilian police indict former President Bolsonaro and aides over alleged 2022 coup attempt

Baku: Countries agreed on Sunday to an annual finance target of $460 billion to help poorer countries deal with the impacts of climate change, with rich countries leading the payments, according to a hard fought deal clinched at the COP29 conference in Baku. The new goal is intended to replace developed countries’ previous commitment to provide $150 billion per year in climate finance for poorer nations by 2020. That goal was met two years late, in 2022, and expires in 2025. Activists participate in a demonstration for climate finance at the COP29 UN Climate Summit. Credit: AP Countries also agreed on rules for a global market to buy and sell carbon credits that proponents say could mobilise billions more dollars into new projects to help fight global warming, from reforestation to deployment of clean energy technologies. On Saturday, negotiators went from one big room where everyone tried to hash out a deal together into several separate huddles of upset nations. More to come ReutersAlex's best bet: New England Patriots at Miami Dolphins prediction

Trump brings back government by social mediaBy Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) What to know about the stroke device The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. How it worked on the first Jackson patient Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. More about the device Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.

Google’s Whisk Reimagines AI Image Creation: Ditch the Text, Embrace the Visual

Buchanan scores 28 off the bench, Boise State downs South Dakota State 83-82Alcoa stock soars to 52-week high, hits $46.57 amid market rallyThe need is for domain experts, but within the civil service

Warren Buffett gives away another $1.1B and plans for distributing his $147B fortune after his death

D램 가격 하락에 미국 제재까지... 한국에 일찍 온 반도체의 겨울This is the next catalyst that could push Nvidia stock up to 27% higher by January, according to Citi